Home Education MDM2 counteracts resistance to CDK4/6 inhibitors for melanoma therapy

MDM2 counteracts resistance to CDK4/6 inhibitors for melanoma therapy

by Staff
6 views

A study has identified a possible second-line treatment for melanoma patients.

Source: sciencedaily.com

Related Articles